Economic burden of sickle cell disease in Brazil

• Ana Cristina Silva-Pinto,

  Roles Writing – original draft, Writing – review & editing

  Affiliations Regional Blood Center, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil, Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil

  ⨯
• Fernando F. Costa,

  Roles Writing – original draft, Writing – review & editing

  Affiliation School of Medical Sciences, University of Campinas, Campinas, SP, Brazil

  ⨯
• Sandra Fatima Menosi Gualandro,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Hematology, University of São Paulo School of Medicine, São Paulo, Brazil

  ⨯
• Patricia Belintani Blum Fonseca,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Pediatric Hematology, Darcy Vargas Children’s Hospital, São Paulo, Brazil

  ⨯
• Carmela Maggiuzzu Grindler,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Technical Area of Neonatal, São Paulo State Health Department: Secretaria da Saude do Estado de Sao Paulo, São Paulo, Brazil

  ⨯
• Homero C. R. Souza Filho,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Novartis Oncology, São Paulo, Brazil

  ⨯
• Carolina Tosin Bueno ,

  Roles Writing – original draft, Writing – review & editing

  * E-mail: carolina.bueno@novartis.com

  Affiliation Novartis Oncology, São Paulo, Brazil

  https://orcid.org/0000-0001-9190-5339

  ⨯
• Rodolfo D. Cançado

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Hematology/Oncology, Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil

  ⨯